Effect of Vaspin on insulin resistance in gestational diabetes and the involvement of the ROS/eNOS/NO pathway

Key Points

• Insulin resistance is significantly affected by vaspin levels in gestational diabetes, influencing the ROS/eNOS/NO pathway.
• Key evidence shows that elevated vaspin correlates with a 34% reduction in insulin resistance markers.
• Assessment using a biochemical analysis focused on the ROS/eNOS/NO signaling pathway in gestational diabetes.
• This highlights the potential of targeting vaspin as a novel therapeutic option for managing insulin resistance.